Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Letter.
Roberto FerraraSandrine SusiniAurelien MarabellePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2018)